Contact this trialFirst, we need to learn more about you.
Anti-cancer agent
ACR-368 + Gemcitabine for Head and Neck Cancer
Recruiting1 awardPhase 2
Tampa, Florida
This trial aims to see how well ACR-368 (prexasertib) works with gemcitabine in patients with Head and Neck Squamous Cell Carcinoma. Patients will receive
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service